Compliant Analysis of Patient Samples and Data

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-03-17

Study Completion Date

2030-08-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients of scientific interest who have provided a commercial sample to LabCorp or one of its' affiliates will have their de-identified remnant samples and/or data used for research and development. Other commercial patients will be followed up on after informed consent is obtained.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Collection and Distribution of Biospecimens for Novel Research Uses

NCT03848962

Cancer Healthy Gastrointestinal Complication +5 more

RECRUITING

A Normal Donor Sample Collection Study in Healthy Adults

NCT01318863

Healthy Normal Volunteers

COMPLETED

Distribution of Biospecimens From Biorepositories/Biobanks for Research Use

NCT03884400

Cancer Pregnancy Related Gastro-Intestinal Disorder +6 more

WITHDRAWN

A Multi-Center Protocol for Obtaining and Storing Human Samples for Immediate or Future Microbial, Immune, or Host Microbe Scientific Study

NCT00765141

Infection

WITHDRAWN

A Multi-Center Protocol for Obtaining and Storing Human Samples for Immediate or Future Microbial, Immune, or Host-Microbe Scientific Study

NCT00764023

Infections

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Arm 1 - Remnant commercial samples and data that has been de-identified of personal health information in compliance with HIPAA may be used for R\&D studies or population-based analysis by LabCorp or affiliates.

Arm 2 - Collection of samples and/or data from commercial test patients requiring follow-up or from subjects of scientific interest after informed consent is obtained.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pregnancy Related Cancer Infectious Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Multiple interventions depending on diagnostic test being run.

Remnant samples and corresponding data from multiple diagnostic tests will be stored for future research and development.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Arm 1
* All samples and data are de-identified and HIPAA compliant
* Arm 2
* Subject is of scientific interest to the Sponsor or treating physician
* Subject provides written informed consent and has a clinical sample and/or supporting clinical data collected.

Exclusion Criteria

* Arm 1
* Subject is from a US state or a country where local law restricts the use of de-identified data and/or remnants of specimens for research and/or development
* Arm 2
* Any medical or mental condition that would interfere with the subjects' ability to willingly give written informed consent

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes